Pancreatic cancer trials in Singapore
9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Singapore
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - Phase 1Not yet taking people in SingaporeStudy of MC001 in Patients With Advanced Solid Tumours
- Where
- Singapore
- Age
- 21 years to 99 years
- People
- 80
- Run by
- National University Hospital, Singapore
See details and how to joinNCT07929961 - No phaseTaking peoplePancreatic Cancer Early Detection Consortium
- Where
- Singapore
- Age
- 18 years to 90 years
- People
- 20,000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056 - Phase 1/2Taking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Singapore
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Singapore
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - Phase 3Taking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Singapore
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Bukit Merah, Singapore
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 2Taking peopleMetronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
- Where
- Singapore
- Age
- 21 years to 99 years
- People
- 50
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT05929885 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Singapore
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00